Zions Bancorporation N.A. increased its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 69.0% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 69,710 shares of the technology company's stock after acquiring an additional 28,454 shares during the quarter. Zions Bancorporation N.A.'s holdings in Relx were worth $3,166,000 as of its most recent SEC filing.
A number of other large investors have also added to or reduced their stakes in the business. CENTRAL TRUST Co grew its stake in Relx by 1,290.2% in the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company's stock valued at $26,000 after buying an additional 529 shares during the last quarter. Versant Capital Management Inc bought a new stake in shares of Relx during the fourth quarter worth approximately $31,000. Sierra Ocean LLC acquired a new position in shares of Relx in the fourth quarter valued at approximately $43,000. Private Trust Co. NA increased its stake in shares of Relx by 119.9% during the third quarter. Private Trust Co. NA now owns 1,038 shares of the technology company's stock worth $49,000 after purchasing an additional 566 shares during the period. Finally, Whipplewood Advisors LLC acquired a new stake in Relx during the 4th quarter worth approximately $74,000. Institutional investors own 15.02% of the company's stock.
Analyst Ratings Changes
A number of research firms have recently weighed in on RELX. Redburn Atlantic began coverage on Relx in a report on Wednesday, January 8th. They set a "buy" rating for the company. Barclays upgraded shares of Relx from an "equal weight" rating to an "overweight" rating in a research note on Friday, March 14th. StockNews.com cut shares of Relx from a "buy" rating to a "hold" rating in a report on Tuesday, March 4th. Finally, The Goldman Sachs Group began coverage on Relx in a research note on Wednesday. They issued a "buy" rating for the company. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Buy".
View Our Latest Report on Relx
Relx Price Performance
Relx stock traded up $0.14 during trading hours on Friday, reaching $50.21. 560,996 shares of the stock were exchanged, compared to its average volume of 757,401. The company has a current ratio of 0.52, a quick ratio of 0.47 and a debt-to-equity ratio of 1.46. Relx Plc has a twelve month low of $40.25 and a twelve month high of $51.99. The company has a market cap of $93.18 billion, a P/E ratio of 26.99, a price-to-earnings-growth ratio of 2.73 and a beta of 0.90. The stock has a 50 day moving average of $49.48 and a two-hundred day moving average of $47.82.
Relx Increases Dividend
The company also recently declared a semi-annual dividend, which will be paid on Wednesday, June 25th. Investors of record on Friday, May 9th will be given a dividend of $0.5586 per share. This is a positive change from Relx's previous semi-annual dividend of $0.23. The ex-dividend date of this dividend is Friday, May 9th. This represents a dividend yield of 1.6%. Relx's dividend payout ratio (DPR) is currently 59.68%.
About Relx
(
Free Report)
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Further Reading

Before you consider Relx, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Relx wasn't on the list.
While Relx currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.